These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25868666)

  • 1. Amyloidosis in alkaptonuria.
    Millucci L; Braconi D; Bernardini G; Lupetti P; Rovensky J; Ranganath L; Santucci A
    J Inherit Metab Dis; 2015 Sep; 38(5):797-805. PubMed ID: 25868666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaptonuria is a novel human secondary amyloidogenic disease.
    Millucci L; Spreafico A; Tinti L; Braconi D; Ghezzi L; Paccagnini E; Bernardini G; Amato L; Laschi M; Selvi E; Galeazzi M; Mannoni A; Benucci M; Lupetti P; Chellini F; Orlandini M; Santucci A
    Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new light on Alkaptonuria: A Fourier-transform infrared microscopy (FTIRM) and low energy X-ray fluorescence (LEXRF) microscopy correlative study on a rare disease.
    Mitri E; Millucci L; Merolle L; Bernardini G; Vaccari L; Gianoncelli A; Santucci A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1000-1008. PubMed ID: 28192171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.
    Braconi D; Millucci L; Bernini A; Spiga O; Lupetti P; Marzocchi B; Niccolai N; Bernardini G; Santucci A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):135-146. PubMed ID: 27865997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and proteomic characterization of alkaptonuric chondrocytes.
    Braconi D; Bernardini G; Bianchini C; Laschi M; Millucci L; Amato L; Tinti L; Serchi T; Chellini F; Spreafico A; Santucci A
    J Cell Physiol; 2012 Sep; 227(9):3333-43. PubMed ID: 22213341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.
    Millucci L; Ghezzi L; Paccagnini E; Giorgetti G; Viti C; Braconi D; Laschi M; Geminiani M; Soldani P; Lupetti P; Orlandini M; Benvenuti C; Perfetto F; Spreafico A; Bernardini G; Santucci A
    Mediators Inflamm; 2014; 2014():258471. PubMed ID: 24876668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review.
    Ranganath LR; Norman BP; Gallagher JA
    J Inherit Metab Dis; 2019 Sep; 42(5):776-792. PubMed ID: 31282009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ex vivo organotypic culture model of alkaptonuria-ochronosis.
    Tinti L; Spreafico A; Chellini F; Galeazzi M; Santucci A
    Clin Exp Rheumatol; 2011; 29(4):693-6. PubMed ID: 21813063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
    Braconi D; Millucci L; Bernardini G; Santucci A
    Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria.
    Bernardini G; Leone G; Millucci L; Consumi M; Braconi D; Spiga O; Galderisi S; Marzocchi B; Viti C; Giorgetti G; Lupetti P; Magnani A; Santucci A
    J Cell Physiol; 2019 May; 234(5):6696-6708. PubMed ID: 30341892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
    Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
    Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.
    Braconi D; Bianchini C; Bernardini G; Laschi M; Millucci L; Spreafico A; Santucci A
    J Inherit Metab Dis; 2011 Dec; 34(6):1163-76. PubMed ID: 21874298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoskeleton Aberrations in Alkaptonuric Chondrocytes.
    Geminiani M; Gambassi S; Millucci L; Lupetti P; Collodel G; Mazzi L; Frediani B; Braconi D; Marzocchi B; Laschi M; Bernardini G; Santucci A
    J Cell Physiol; 2017 Jul; 232(7):1728-1738. PubMed ID: 27454006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raman Spectroscopy identifies differences in ochronotic and non-ochronotic cartilage; a potential novel technique for monitoring ochronosis.
    Taylor AM; Jenks DD; Kammath VD; Norman BP; Dillon JP; Gallagher JA; Ranganath LR; Kerns JG
    Osteoarthritis Cartilage; 2019 Aug; 27(8):1244-1251. PubMed ID: 31022456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R
    Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria.
    Bernardini G; Laschi M; Geminiani M; Braconi D; Vannuccini E; Lupetti P; Manetti F; Millucci L; Santucci A
    J Inherit Metab Dis; 2015 Sep; 38(5):807-14. PubMed ID: 25762405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
    Millucci L; Bernardini G; Spreafico A; Orlandini M; Braconi D; Laschi M; Geminiani M; Lupetti P; Giorgetti G; Viti C; Frediani B; Marzocchi B; Santucci A
    Calcif Tissue Int; 2017 Jul; 101(1):50-64. PubMed ID: 28271171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of secondary amyloidosis in alkaptonuria.
    Millucci L; Ghezzi L; Bernardini G; Braconi D; Lupetti P; Perfetto F; Orlandini M; Santucci A
    Diagn Pathol; 2014 Sep; 9():185. PubMed ID: 25567001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.
    Spreafico A; Millucci L; Ghezzi L; Geminiani M; Braconi D; Amato L; Chellini F; Frediani B; Moretti E; Collodel G; Bernardini G; Santucci A
    Rheumatology (Oxford); 2013 Sep; 52(9):1667-73. PubMed ID: 23704321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre.
    Ranganath LR; Khedr M; Milan AM; Davison AS; Hughes AT; Usher JL; Taylor S; Loftus N; Daroszewska A; West E; Jones A; Briggs M; Fisher M; McCormick M; Judd S; Vinjamuri S; Griffin R; Psarelli EE; Cox TF; Sireau N; Dillon JP; Devine JM; Hughes G; Harrold J; Barton GJ; Jarvis JC; Gallagher JA
    Mol Genet Metab; 2018 Sep; 125(1-2):127-134. PubMed ID: 30055994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.